Edwards Lifesciences Corporation
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $1.89B | $4.51B | $930.1M |
| FY2017 | $2.71B | $5.67B | $818.3M |
| FY2018 | $2.18B | $5.32B | $714.1M |
| FY2019 | $2.34B | $6.49B | $1.18B |
| FY2020 | $2.66B | $7.24B | $1.18B |
| FY2021 | $2.67B | $8.50B | $862.8M |
| FY2022 | $2.49B | $8.29B | $769.0M |
| FY2023 | $2.64B | $9.36B | $1.13B |
| FY2024 | $2.99B | $13.06B | $3.05B |
| FY2025 | $3.36B | $13.70B | $2.94B |